• Non ci sono risultati.

Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania

N/A
N/A
Protected

Academic year: 2021

Condividi "Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania"

Copied!
3
0
0

Testo completo

(1)

Short

Communication

Absence

of

hepatitis

delta

infection

in

a

large

rural

HIV

cohort

in

Tanzania

Annja

Winter

a

,

Emilio

Letang

b,c,d

,

Aneth

Vedastus

Kalinjuma

c

,

Namvua

Kimera

c

,

Alex

Ntamatungiro

c

,

Tracy

Glass

b

,

Darius

Moradpour

e

,

Roland

Sahli

f

,

Fre´de´ric

Le

Gal

g

,

Hansjakob

Furrer

a

,

Gilles

Wandeler

a,h,i,

*

and

the

KIULARCO

Study

Group

aDepartmentofInfectiousDiseases,BernUniversityHospital,UniversityofBern,CH-3010Bern,Switzerland bSwissTropicalandPublicHealthInstitute,Basel,Switzerland

c

IfakaraHealthInstitute,Ifakara,UnitedRepublicofTanzania

d

ISGlobal,BarcelonaCtr.Int.HealthRes.(CRESIB),HospitalClı´nic—UniversitatdeBarcelona,Barcelona,Spain

e

DivisionofGastroenterologyandHepatology,CentreHospitalierUniversitaireVaudois,UniversityofLausanne,Lausanne,Switzerland

f

InstituteofMicrobiology,CentreHospitalierUniversitaireVaudois,UniversityofLausanne,Lausanne,Switzerland

g

HoˆpitauxUniversitairesParis-Seine-Saint-Denis,Paris,France

hDepartmentofInfectiousDiseases,UniversityofDakar,Dakar,Senegal iInstituteofSocialandPreventiveMedicine,UniversityofBern,Bern,Switzerland

1. Introduction

Worldwide,5%ofindividualswithchronichepatitisBvirus (HBV)infectionhaveserologicalevidenceofexposuretohepatitis deltavirus(HDV).1 HBV/HDVco-infectedindividualsgenerally

havemoresevereliverdiseasethanHDV-uninfectedindividuals.

Only limited data on HDV infection are available from Sub-SaharanAfrica (SSA); prevalenceestimates rangefrom zeroin hepatitis B surface antigen (HBsAg)-positive individuals in Mozambiqueto53%intheCentralAfricanRepublic.2,3Theaim

ofthisstudywastodeterminetheprevalence,aswellasthemain epidemiologicalandclinical determinants,of HDVinfectionin HIV/HBVco-infectedindividualsinrural Tanzania.Toestimate theproportionoffalse-positiveHDVscreeningtests,allpositive sampleswereretestedwithasecondserologicalassayandnucleic acidamplification.

InternationalJournalofInfectiousDiseases46(2016)8–10

ARTICLE INFO Articlehistory:

Received13January2016

Receivedinrevisedform8March2016 Accepted13March2016

CorrespondingEditor:EskildPetersen, Aarhus,Denmark. Keywords: Hepatitisdelta HIV Tanzania False-positiveserology Sub-SaharanAfrica SUMMARY

Objectives:Theepidemiologicalandclinicaldeterminantsofhepatitisdeltavirus(HDV)infectionin

Sub-SaharanAfricaareill-defined.TheprevalenceofHDVinfectionwasdeterminedinHIV/hepatitisBvirus

(HBV)co-infectedindividualsinruralTanzania.

Methods:AllHBV-infectedadultsunderactivefollow-upintheKilomberoandUlangaAntiretroviral

Cohort(KIULARCO)werescreenedforanti-HDVantibodies.Forpositivesamples,asecondserological

test and nucleic acid amplification were performed. Demographic and clinical characteristics at

initiationof antiretroviraltherapy(ART)werecomparedbetweenanti-HDV-negative and-positive

patients.

Results:Among222HIV/HBVco-infectedpatientsonART,219(98.6%)hadastoredserumsample

availableandwereincludedinthestudy.Medianagewas37years,55%werefemale,46%hadWorld

HealthOrganizationstageIII/IVHIVdisease,andthemedianCD4countwas179cells/ml.Theprevalence

ofanti-HDVpositivitywas5.0%(95%confidenceinterval2.8–8.9%).Therewasnosignificantpredictorof

anti-HDVpositivity.HDVcouldnotbeamplifiedinanyoftheanti-HDV-positivepatientsandthesecond

serologicaltestwasnegativeinallofthem.

Conclusions: NoconfirmedcaseofHDVinfectionwas foundamong over200HIV/HBV co-infected

patients in Tanzania. As false-positive serology results are common, screening results should be

confirmedwithasecondtest.

ß2016TheAuthors.PublishedbyElsevierLtdonbehalfofInternationalSocietyforInfectiousDiseases.

ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(

http://creativecommons.org/licenses/by-nc-nd/4.0/).

* Correspondingauthor.Tel.:+41316322525.

E-mailaddress:gilles.wandeler@ispm.unibe.ch(G.Wandeler).

ContentslistsavailableatScienceDirect

International

Journal

of

Infectious

Diseases

j o urn a l hom e pa ge : ww w. e l s e v i e r. c om/ l o ca t e / i j i d

http://dx.doi.org/10.1016/j.ijid.2016.03.011

1201-9712/ß2016TheAuthors.PublishedbyElsevierLtdonbehalfofInternationalSocietyforInfectiousDiseases.ThisisanopenaccessarticleundertheCCBY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).

(2)

2. Methods

Thestudy was conductedwithin theKilomberoand Ulanga AntiretroviralCohort(KIULARCO) inIfakara, Tanzania.4 AllHIV/

HBV-co-infectedadults(15yearsofage)withatleastabaseline andonefollow-upvisitbetweenJanuary2013andDecember2014, and who started antiretroviral therapy (ART) before December 2014, were included. All participants gave written informed consent.Ethicalapproval wasobtained fromtheIfakaraHealth InstituteinstitutionalreviewboardandfromtheNationalInstitute forMedicalResearchofTanzania.

SerumHBsAgwastestedusingarapidtest(AbonBiopharm, Hangzou,China). The ETI-AB-DELTA-2test (DiaSorin,Brussels, Belgium)was used toscreen foranti-HDV antibodies; results were considered positive when the optical density (OD) was <0.9.Asecondserologicaltestwasusedasconfirmation (HDV-Ab kit; DiaPro, Milan, Italy, used on an ETI-Max (DiaSorin) platform).The resultwas considered negative whenthe ratio (threshold/OD) was <0.9. For the measurement of HDV viral load,totalnucleicacidswerepurifiedfromplasma(QiagenEZ1 DSPkit),andcDNA(HighCapacitycDNAReverseTranscription Kit; Applied Biosystems) was subjected to real-time PCR according to Ferns et al.,5 with minor modifications. The

detectionlimit was 1000 genome equivalentsper milliliter of plasma.

Anti-HDV prevalence was described with a 95% confidence interval(CI).Fisher’sexacttestandtheWilcoxonranksumtest were used to compare individual characteristics at ART start between anti-HDV-positive and negative individuals. Analyses

weredoneusingSASversion9.3software(SASInstitute,Cary,NC, USA).

3. Results

Of 222 HBsAg-positive patients on ART, 219 (98.6%) had a storedsampleavailableforHDVserology.Themedianageofthe patients was37 years,55%werefemale,46%had WorldHealth OrganizationstageIII/IVHIVdisease,andthemedianbaselineCD4 countwas179cells/

m

l.

Theprevalenceofanti-HDVantibody-positivitywas5.0%(11/ 219, 95% CI 2.8–8.9%) with the screening test. In all positive samples, the OD ranged between 0.60 and 0.91(median 0.81, interquartile range(IQR)0.65–0.87),whilethepositivecontrols had OD values between 0.05 and 0.09. Among 11 anti-HDV-positivesamples,nonewaspositivewiththesecondanti-HDVtest (negative controls all had a DiaPro ratio (threshold/OD) <0.9;

Table1).HDVRNAcouldnotbeamplifiedinanyofthepatients witha positive screeningtest. Positive real-timePCR resultsof spiked internalRNAcontrolsconfirmedthatHDVRNA-negative resultsweretruenegatives(datanotshown).

The ageand sexdistribution, aswell as medianbody mass index,CD4cellcount,and alanineaminotransferaselevelswere similar between anti-HDV-positive and -negative individuals (Table 2). The estimated glomerular filtrationrate wasslightly lower in HDV-positive individuals compared to HDV-negative individuals(p=0.05).

4. Discussion

Inthiscohortofover200HIV/HBVco-infectedindividualsin rural Tanzania, no confirmedcase of activeHDV infectionwas found. Five percent of the patients had a positive anti-HDV antibodyscreeningtest,butthesecondserologyandnucleicacid amplificationwerenegativeinallofthem.Asnodemographicor clinicalpredictorofanti-HDVfalse-positivitywasidentified,these resultssuggestthatweaklypositive(ODvalues0.1–0.9)anti-HDV screeningresultsshouldbeconfirmedwithanadditionaltest.

There appeartobenopublisheddataon HDVprevalence in Tanzaniaatthecurrenttime.Inlinewiththeresultsofthisstudy, reports from neighboring countries Mozambique and Burundi haveshowntheabsenceofHDVinfection,whereasananti-HDV antibody prevalence of 53% has been described in theCentral AfricanRepublic.2,3,6AsthereseemtobelargedifferencesinHDV

prevalenceacrossandevenwithincountries,furtherresearchis neededtoimproveourknowledgeonHDVinfectioninSSA. Table1

Serologyresultsfor11patientswithapositiveanti-HDVscreeningtesta

Patient DiaSorinOD DiaProratio

1 0.87 0.49 2 0.62 0.18 3 0.65 0.19 4 0.81 0.21 5 0.87 0.18 6 0.71 0.20 7 0.60 0.19 8 0.83 0.21 9 0.89 0.18 10 0.91 0.27 11 0.73 0.19

HDV,hepatitisdeltavirus;OD,opticaldensity.

a

Positiveresult:DiaSorinOD<0.9,DiaProratio(threshold/OD)>0.9.

Table2

Baselinecharacteristicsbyanti-HDVscreeningresult

Baselinecharacteristics HDVscreeningtestresult p-Value

Anti-HDVnon-reactive(n=208) Anti-HDVreactive(n=11)a Sex,n(%)

Female 114(54.8) 5(45.5) 0.55

Male 94(45.2) 6(54.6)

Age,years,median(IQR) 37(31–44) 37(30–44) 0.77

BMI,kg/m2

,median(IQR) 20.3(18–23) 20.8(17–23.5) 0.98

CD4cellcount,cells/ml,median(IQR) 174(66–275) 214(84–337.5) 0.69

ALT,IU/ml,median(IQR) 23.0(11.0–39.6) 26.6(13.7–54.0) 0.36

eGFR,ml/min,median(IQR) 132.3(110.6–146.1) 115.4(105.1–124.4) 0.05

InitialARTregimen(%) 0.18

3TC/D4T/NVP 39(18.8) 0

3TC/AZT/EFV 63(30.3) 5(45.4)

XTC/TDF/EFV 77(37.0) 6(54.6)

Other 29(13.9) 0

HDV,hepatitisdeltavirus;IQR,interquartilerange;BMI,bodymassindex;ALT,alanineaminotransferase;eGFR,estimatedglomerularfiltrationratebasedontheCKD-EPI formula;ART,antiretroviraltherapy;3TC,lamivudine;D4T,stavudine;NVP,nevirapine;AZT,zidovudine;EFV,efavirenz;XTC,lamivudineoremtricitabine;TDF,tenofovir.

a

UsingETI-AB-DELTA-2(DiaSorin).

(3)

Allpatientswithafalse-positivescreeningtesthadaweakly positiveresult.Thus,thecut-offrecommendedbythe manufac-turerappearsinappropriateinthepresentstudysetting. Unfortu-natelyitwasnotpossibletocalculatethespecificityoftheHDV antibodyscreeningtestaspatientswithanegativeresultwerenot testedwith thesecondserology. However, ifthepatients with a negative screening test were all truly HDV-uninfected, the specificitywouldbe95%(95%CI91–97%).Althoughnopredictorof anti-HDVfalse-positivitywasidentifiedinthiscohort,thepower todetectsuchadifferencewasverylimited.Govindarajanetal. suggestedthatlipemicserumorthepresenceofrheumatoidfactor were associated with false-positive anti-HDV immunoassay results.7Unfortunatelyitwasnotpossibletotestthesehypotheses

asdataonlipidswereunavailable.

Insummary,HDVinfectionwasfoundtoberareinHIV/HBV co-infected individuals in rural Tanzania. To avoid the over-estimation of HDV prevalence, future studies should confirm serologicalresultswithasecondtest,especiallyinpatientswitha weaklypositiveETI-AB-DELTA-2testresult.

Acknowledgements

We thank all patients and staff for their participation. The Kilombero and Ulanga Antiretroviral Cohort and the Chronic Diseases Clinic of Ifakara receive financial support from the GovernmentoftheCantonofBasel,Switzerland,theSwissTropical and Public Health Institute, the Ifakara Health Institute, the GovernmentofTanzania,andUSAIDthroughTUNAJALI-Deloitte. GWwassupportedbyanAmbizione-PROSPERfellowshipfromthe SwissNationalScienceFoundation(PZ00P3_154730).

The members of the KIULARCO Study Group are: Aschola Asantiel,Manuel Battegay, AdolphinaChale, DianaFaini, Ingrid

Felger,GideonFrancis,HansjakobFurrer,AnnaGamell,TracyGlass, Christoph Hatz, Speciosa Hwaya, Aneth Vedastus Kalinjuma, BrysonKasuga,NamvuaKimera,YassinKisunga,ThomasKlimkait, Emilio Letang, Antonia Luhombero, Lameck B. Luwanda, Herry Mapesi,LeticiaMbwile,MengiMkulila,JuliusMkumbo,Margareth Mkusa,DorcusKMnzava,GermanaMossad,DoloresMpundunga, AthumaniMtandanguo,KimD.Mwamelo,SelerineMyeya,Sanula Nahota,ReginaNdaki,AgathaNgulukila,AlexJohnNtamatungiro, Leila Samson, George Sikalengo, Marcel Tanner, and Fiona Vanobberghen.

Conflictofinterest:Theauthorsdeclarenoconflictsofinterest.

References

1.RizzettoM.HepatitisD:thirtyyearsafter.JHepatol2009;50:1043–50.

2.CunhaL,PlouzeauC,IngrandP,GudoJP,IngrandI,MondlaneJ,etal.Useof replacementblooddonorstostudytheepidemiologyofmajorblood-borne viruses in the general population of Maputo, Mozambique. J Med Virol 2007;79:1832–40.

3.BekondiC,MobimaT,OuaveneJO,KoffiB,KonamnaX,BereA,etal. [Etiopatho-logicalfactorsofhepatocellularcarcinomainBangui,CentralAfricanRepublic: clinical,biologicalcharacteristicsandvirologicalaspectsofpatients].PatholBiol (Paris)2010;58:152–5.

4.HarakaF,GlassTR,SikalengoG,GamellA,NtamatungiroA,HatzC,etal.Abundle ofservicesincreasedascertainmentoftuberculosisamongHIV-infected indi-vidualsenrolledinaHIVcohortinruralSub-SaharanAfrica.PLoSOne2015;10: e0123275.

5.FernsRB,NastouliE,GarsonJA.Quantitationofhepatitisdeltavirususinga single-stepinternallycontrolledreal-timeRT-qPCRandafull-lengthgenomic RNAcalibrationstandard.JVirolMethods2012;179:189–94.

6.deLallaF,RizzardiniG,RinaldiE,SantoroD,ZeliPL,VergaG.HIV,HBV, delta-agentandTreponemapalliduminfectionsintworuralAfricanareas.TransRSoc TropMedHyg1990;84:144–7.

7.GovindarajanS,ValinluckB,Lake-BakkarG.Evaluationofacommercial anti-deltaEIAkitfordetectionofantibodiestohepatitisdeltavirus.AmJClinPathol 1991;95:240–1.

A.Winteretal./InternationalJournalofInfectiousDiseases46(2016)8–10 10

Figura

Table 1 ). HDV RNA could not be amplified in any of the patients with a positive screening test

Riferimenti

Documenti correlati

Per i valori di Rs, all’incirca media dei consumi energetici del patrimonio edilizio esistente, si può fare ricorso ai dati pubblicati dall’ENEA ; confrontando tali dati con

Evaluation of Resistance in Patients Who Had Failed Therapy The prevalence of drug resistance was evaluated, and strati fied according to different viremia levels, in a subset of

followed here with an idea of using the Zn-only ends as INAS facilitating Tooeleite nucleation within the overall neutral aqueous media. Three different water samples were

Laser Medicine srl) è un test per la rivelazione qualitativa di HDV in campioni di siero/plasma che si basa su quattro pro- cessi principali: 1) estrazione dell’RNA dal campione;

pylori effect on the quality of life in Parkinson’s disease patients; to detect the risk factors for H.. Sociodemographic characteristics, previous antibiotic use, medical and

Per tentare di recuperare questo deficit, abbiamo trattato gli animali con il fattore di crescita IGF-1 (Insulin-like Growth Factor-1), che si era già dimostrato efficace nel

A cost model, associated to the abstract architecture, has to sum up all the features of the concrete architecture e.g., how cache coherency state affects the memory and cache

In the general context of American foreign policy in the Sixties, the Mediterranean was at the same time a theatre of bipolar confrontation, that is, an area to defend from